POPULARITY
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289 Overview: Excessive screen time has been associated with numerous adverse health outcomes. Join us for a look at a fascinating new study that explores how limiting screen time can increase physical activity in children. Listen to this brief podcast before you counsel your next patient on how screen time can affect their children's (and their) health. Episode resource links: Pedersen J,et al. Effects of Limiting Recreational Screen Media Use on Physical Activity and Sleep in Families With Children: A Cluster Randomized Clinical Trial. JAMA Pediatr. 2022 May 23:e221519 Screen Time and Children. American Academy of Child and Adolescent Psychiatry: https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289 Overview: Excessive screen time has been associated with numerous adverse health outcomes. Join us for a look at a fascinating new study that explores how limiting screen time can increase physical activity in children. Listen to this brief podcast before you counsel your next patient on how screen time can affect their children's (and their) health. Episode resource links: Pedersen J,et al. Effects of Limiting Recreational Screen Media Use on Physical Activity and Sleep in Families With Children: A Cluster Randomized Clinical Trial. JAMA Pediatr. 2022 May 23:e221519 Screen Time and Children. American Academy of Child and Adolescent Psychiatry: https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/struggling-with-weight-loss In the context of a clinical case, faculty will explain how to use patient-centered communication to present pharmacotherapeutic options for weight loss and blood glucose management that follow evidence-based guidelines.
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-285 Overview: Join us for a closer look at tirzepatide, a first-in-class glucose-dependent insulinotropic peptide (GIP) and a glucagon-like peptide-1 receptor agonist (GLP-1 RA). See how this novel glucose-lowering agent can help raise the bar in both HbA1c lowering and weight loss in patients with type 2 diabetes mellitus. Episode resource links: Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 May 17:1–11. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-283 Overview: Listen to this podcast to hear a simple method to help those with COPD improve their symptom control and lower exacerbation rates. Episode resource links: Am J Respir Crit Care Med Vol 205, Iss 4, pp 421–430, Feb 15, 2022 Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/migraine-and-cardiovascular-disease-case Overview: This podcast will focus on the case of a patient with a long history of periodic migraine attacks whose previously preferred acute medication is now contraindicated because of a recently acquired comorbid condition. Faculty will consider newer medication options for this patient that will take into account his employment requirements and individual preferences, as well as his medical history.
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/your-questions-about-migraine Overview: In this podcast, Dr. Dawn Buse will address questions about migraine diagnosis and treatment posed by Pri-Med learners during recent programs. Topics will include deciding when imaging is appropriate in the evaluation of headache, distinguishing between migraine and cluster headache, determining which patients would benefit from preventive migraine therapy, considering how long to use a preventive therapy before determining it to be ineffective, managing menstrual migraines, and treating migraine in children and adolescents.
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281 Overview: Clinicians may hesitate to provide medication abortion without first performing a pelvic ultrasound or pelvic examination, but recent data may give clinicians more confidence in their decision to do so. This episode explores the evidence for the safety of telehealth-based, or no-test screening, approaches to providing medication abortion for pregnant women at less than 10 weeks' gestation. Episode resource links: Upadhyay UD, Raymond EG, Koenig LR, et al. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study. JAMA Intern Med. Published online March 21, 2022. doi:10.1001/jamainternmed.2022.0217 Upadhyay UD, Koenig LR, Meckstroth KR. Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic. JAMA Network Open. 2021;4(8):e2122320. doi:10.1001/jamanetworkopen.2021.22320 Endler M, Lavelanet A, Cleeve A, Ganatra B, Gomperts R, Gemzell-Danielsson K. Telemedicine for medical abortion: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2019;126(9):1094-1102. doi:10.1111/1471-0528.15684 Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281 Overview: Clinicians may hesitate to provide medication abortion without first performing a pelvic ultrasound or pelvic examination, but recent data may give clinicians more confidence in their decision to do so. This episode explores the evidence for the safety of telehealth-based, or no-test screening, approaches to providing medication abortion for pregnant women at less than 10 weeks' gestation. Episode resource links: Upadhyay UD, Raymond EG, Koenig LR, et al. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study. JAMA Intern Med. Published online March 21, 2022. doi:10.1001/jamainternmed.2022.0217 Upadhyay UD, Koenig LR, Meckstroth KR. Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic. JAMA Network Open. 2021;4(8):e2122320. doi:10.1001/jamanetworkopen.2021.22320 Endler M, Lavelanet A, Cleeve A, Ganatra B, Gomperts R, Gemzell-Danielsson K. Telemedicine for medical abortion: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. 2019;126(9):1094-1102. doi:10.1111/1471-0528.15684 Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/multi-cancer-early-detection Overview: Carve out 15 minutes in your day to listen to an expert-led podcast on the current landscape of cancer screening and how emerging technology in multi-cancer early detection (MCED) screening tests will likely improve this landscape. Listen while experts define this new technology, explain how it works, and discuss its benefits and limitations. Find out how available and emerging MCED tests can augment your current screening strategies and optimize cancer detection, potentially catching a greater number of early-stage cancers and saving lives.
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/alzheimer-disease-detection-pt2 Overview: This short podcast will focus on new and emerging monoclonal antibody therapies targeting β-amyloid, with a focus on the importance of early recognition and diagnosis of Alzheimer disease to allow prompt treatment for patients in the early stages of the disease who may derive the most benefit from these agents.
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-277 Overview: Join us to discuss a summary of the newly published guidelines for pneumococcal vaccines and to review the most recently approved vaccines. We'll begin by describing the challenges from the previous guidelines and how these new guidelines address these challenges. Given the burden of pneumococcal disease and that vaccination is our best weapon to combat the disease, you won't want to miss this episode. Episode resource links: Morga, A., Kimura, T., Feng, Q., Rozario, N., & Schwartz, J. (2022). Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination. Vaccine. https://www.medscape.com/viewarticle/967675#vp_1 Schulz, P. S., Moore, S. E., Smith, D., Javed, J., & Wilde, A. M. (2022, April). Missed Pneumococcal Vaccination Opportunities in Adults With Invasive Pneumococcal Disease in a Community Health System. In Open Forum Infectious Diseases (Vol. 9, No. 4, p. ofac075). US: Oxford University Press. Center for disease Control and Prevention Resources: App for iphone and android PneumoRecs Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/alzheimer-disease-detection-pt1 Overview: Despite the growing prevalence and devastating effects of Alzheimer disease (AD), mild cognitive impairment (MCI) often goes unrecognized in the primary care setting. This brief podcast highlights the need for primary care providers to identify individuals with MCI as early as possible so they can be assessed and, if diagnosed with AD, treated promptly. Expert faculty will explore the manifold benefits of early evaluation, which can include identifying reversible causes of MCI, taking advantage of new effective treatments, and reducing patients' risk of premature mortality. You'll walk away from this podcast with strategies to help you earlier identify these patients and, ultimately, maintain their cognitive abilities and quality of life for a longer period.
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-276 Overview: The concerns over the use of NSAIDs have been well documented. The medications can raise blood pressure and have been linked to an increased risk of heart disease and stroke when used long term. These known risks, supported by the FDA's warning in 2005, has prompted many clinicians to prescribe acetaminophen instead. But do acetaminophen products confer a lower risk of cardiovascular effects? Join us for this episode to review the results from recent trials assessing similar blood pressure effects from regular use of acetaminophen. Episode resource links: https://doi.org/10.1161/CIRCULATIONAHA.121.056015 Circulation. 2022;145:416–423 https://doi.org/10.1093/eurheartj/ehac059; European Heart Journal. 2,24,2022 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-276 Overview: The concerns over the use of NSAIDs have been well documented. The medications can raise blood pressure and have been linked to an increased risk of heart disease and stroke when used long term. These known risks, supported by the FDA's warning in 2005, has prompted many clinicians to prescribe acetaminophen instead. But do acetaminophen products confer a lower risk of cardiovascular effects? Join us for this episode to review the results from recent trials assessing similar blood pressure effects from regular use of acetaminophen. Episode resource links: https://doi.org/10.1161/CIRCULATIONAHA.121.056015 Circulation. 2022;145:416–423 https://doi.org/10.1093/eurheartj/ehac059; European Heart Journal. 2,24,2022 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-273 Overview: The evidence continues to grow and evolve on the potential harms of e-cigarette use and on their efficacy and safety as a harm reduction strategy. One aspect of e-cigarette use that has not received much attention is the effect of secondhand exposure to the exhaled aerosol from e-cigarettes. Previous small studies have suggested some exposure risk, but a recent study of >2,000 participants found that secondhand exposure to e-cigarette aerosol increased the risk of bronchitic symptoms and shortness of breath in young adults. Join us as we discuss these findings and their implications to practice. Episode resource links: Islam T, Braymiller J, Eckel SP, et al Secondhand nicotine vaping at home and respiratory symptoms in young adults Thorax Published Online First: 10 January 2022. doi: 10.1136/thoraxjnl-2021-217041 Caponnetto P, Caruso M, Maglia M, et al. Non-inferiority trial comparing cigarette consumption, adoption rates, acceptability, tolerability, and tobacco harm reduction potential in smokers switching to Heated Tobacco Products or electronic cigarettes: Study protocol for a randomized controlled trial. Article. Contemporary Clinical Trials Communications. 2020;17100518. doi:10.1016/j.conctc.2020.100518 Gaiha SM, et al. J Adolesc Health. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health. Vol 67, issue 4, pp 519-523; DOI: https://doi.org/10.1015/j.jadolhealth.2020.07.002 Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5 Mayo Clinic. (2022, January 13). E-cigarette users who test positive for COVID-19 are more likely to experience COVID-19 symptoms. ScienceDaily. Retrieved January 17, 2022 from www.sciencedaily.com/releases/2022/01/220113151402.htm McAlinden KD, Eapen MS, Lu W, Chia C, Haug G, Sohal SS. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection? Eur Respir J. 2020. vol. 1. McFadden, DD, Bornstein, SL, Vassallo, R, Salonen, BR, Nadir Bhuiyan, M, Schroeder, DR, Croghan, IK. Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers. Journal of Primary Care & Community Health, 2022; 13: 215013192110626 DOI: 10.1177/21501319211062672 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-273 Overview: The evidence continues to grow and evolve on the potential harms of e-cigarette use and on their efficacy and safety as a harm reduction strategy. One aspect of e-cigarette use that has not received much attention is the effect of secondhand exposure to the exhaled aerosol from e-cigarettes. Previous small studies have suggested some exposure risk, but a recent study of >2,000 participants found that secondhand exposure to e-cigarette aerosol increased the risk of bronchitic symptoms and shortness of breath in young adults. Join us as we discuss these findings and their implications to practice. Episode resource links: Islam T, Braymiller J, Eckel SP, et al Secondhand nicotine vaping at home and respiratory symptoms in young adults Thorax Published Online First: 10 January 2022. doi: 10.1136/thoraxjnl-2021-217041 Caponnetto P, Caruso M, Maglia M, et al. Non-inferiority trial comparing cigarette consumption, adoption rates, acceptability, tolerability, and tobacco harm reduction potential in smokers switching to Heated Tobacco Products or electronic cigarettes: Study protocol for a randomized controlled trial. Article. Contemporary Clinical Trials Communications. 2020;17100518. doi:10.1016/j.conctc.2020.100518 Gaiha SM, et al. J Adolesc Health. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health. Vol 67, issue 4, pp 519-523; DOI: https://doi.org/10.1015/j.jadolhealth.2020.07.002 Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5 Mayo Clinic. (2022, January 13). E-cigarette users who test positive for COVID-19 are more likely to experience COVID-19 symptoms. ScienceDaily. Retrieved January 17, 2022 from www.sciencedaily.com/releases/2022/01/220113151402.htm McAlinden KD, Eapen MS, Lu W, Chia C, Haug G, Sohal SS. COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection? Eur Respir J. 2020. vol. 1. McFadden, DD, Bornstein, SL, Vassallo, R, Salonen, BR, Nadir Bhuiyan, M, Schroeder, DR, Croghan, IK. Symptoms COVID 19 Positive Vapers Compared to COVID 19 Positive Non-vapers. Journal of Primary Care & Community Health, 2022; 13: 215013192110626 DOI: 10.1177/21501319211062672 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-266 Overview: ‘Tis the season for pediatric fevers! Join us to review a recent meta-analysis looking at 18 studies with patients younger than 2 years old who received acetaminophen or ibuprofen for fever or pain to determine if one medication should be recommended first, before the other. After this session, you'll be able to confidently advise parents of young children on how best to manage fever and/or pain at home with over-the-counter medications. Episode resource links: Long B, Gottlieb M. Ibuprofen vs. Acetaminophen for Fever or Pain in Children Younger Than Two Years. Am Fam Physician. 2022 Jan ;105(1):19. Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Evid Based Child Health. 2014 Sep;9(3):675-729. doi: 10.1002/ebch.1978. PMID: 25236309. Sullivan JE, Farrar HC. Fever and Antipyretic Use in Children. Pediatrics (2011) 127 (3): 580-587. (Reaffirmed 2016) Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263 Overview: The FDA's recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer's Paxlovid and Merck's molnupiravir antiviral agents and give you the information you need to confidently prescribe them. Episode resource links: FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov) FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov) Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-254 Overview: Older adults who suffer from loneliness may be at risk of overusing medications prescribed for pain, insomnia, depression, or anxiety. Replacing these medications with social interventions may improve outcomes and help patients avoid adverse consequences. Join us as we discuss the importance of reviewing medications and assessing for loneliness in older adults to prevent adverse events and outcomes. Episode resource links: Kotwal, A. A., Steinman, M. A., Cenzer, I., & Smith, A. K. (2021). Use of High-risk Medications Among Lonely Older Adults: Results From a Nationally Representative Sample. JAMA internal medicine, e213775. Advance online publication. https://doi.org/10.1001/jamainternmed.2021.3775 https://pubmed.ncbi.nlm.nih.gov/34309620/ Education for Patients: Tips on Staying Connected—National Institutes on Aging https://www.nia.nih.gov/health/loneliness-and-social-isolation-tips-staying-connected Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-251 Overview: Primary care providers should be up to date on the changes to the guidelines for cervical cancer screening to be able to guide patients in shared decision-making about health maintenance. Join us to review the recent changes to cervical cancer screening guidelines as recommended by the American Cancer Society. Episode resource links: Cervical Cancer Screening: Updated Guidelines from the American Cancer Society. Am Fam Physician. 2021 Sep; 104(2):314-315. American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. Practice advisory. April 2021. Accessed September 30, 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines Fontham, ETH, Wolf, AMD, Church, TR, et al. Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society. CA Cancer J Clin. 2020. https://doi.org/10.3322/caac.21628. Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-248 Overview: Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event. Episode resource links: New: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication Old: https://www.aafp.org/afp/2016/1015/od1.html https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-248 Overview: Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event. Episode resource links: New: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication Old: https://www.aafp.org/afp/2016/1015/od1.html https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/early-action-in-hcc-episode-three Overview: This podcast is the third in a three-part series addressing the urgency for early identification and improved care for patients with hepatocellular carcinoma (HCC). In this episode, two experts discuss exciting changes in the HCC treatment landscape, and how primary care providers can help with follow-up and care coordination. Guest: Ghassan Abou-Alfa, MD, MBA & Amit G. Singal, MD, MS
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/expanding-access-to-IUDs Overview: In this concise and informative podcast, listen to family planning expert Katharine White, MD, review the current landscape of intrauterine device (IUD) options available to your patients. She will describe the current approved IUD options and a case example to help you understand how to counsel patients about IUDs. After listening, you will be equipped to identify patients who would benefit from IUDs and help these patients pick the best one for them. If you are interested in getting further hands-on training related to IUD insertion, management, and removal, check out the list of resources provided with this activity that can enable you to incorporate this important skill into your practice. Guest: Katharine O'Connell White, MD, MPH
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-247 Overview: When it comes to chronic migraines, your first-line prevention is probably medication, but according to a new study, it may not have to be. Certain foods may play a role in increasing and decreasing migraine recurrence. Join us to review a recent randomized controlled trial aimed at preventing migraines in those with chronic migraines. Episode resource links: BMJ 2021; 374 :n1448 doi:10.1136/bmj.n1448; doi: https://doi.org/10.1136/bmj.n1448 The association of dietary patterns with migraine attack frequency in migrainous women. Nutritional Neuroscience 23:9, pages 724-730 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/early-action-in-hcc-episode-two Overview: This podcast is the second in a three-part series addressing the urgency for early identification and improved care for patients with hepatocellular carcinoma (HCC). In this episode, two experts discuss three HCC patient cases and examine the role of screening and referral in their disease course trajectory. Guest: Ghassan Abou-Alfa, MD, MBA & Amit G. Singal, MD, MS
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-246 Overview: Low back pain often leads to disability and loss of income and is a significant burden on patients and the healthcare system. While muscle relaxants are the third most common prescribed drugs in the treatment of low back pain, recent data demonstrating its use and efficacy are limited. This session discusses a recent systematic review of the safety, efficacy, and accepted use of muscle relaxants in the treatment of low back pain. Don't miss this opportunity to learn how to provide low back pain treatments that have clear benefits for your patients. Episode resource links: Cashin A G, Folly T, Bagg M K, Wewege M A, Jones M D, Ferraro M C et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis BMJ 2021; 374 :n1446 doi:10.1136/bmj.n1446 https://pubmed.ncbi.nlm.nih.gov/34233900/ Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: Overview: In this short podcast, you will hear guideline-based answers to important questions about managing influenza in the pediatric population. Find out which children are considered high risk for complications and what those risks mean for vaccine selection. Hear expert tips on how to discuss the sensitive issue of influenza vaccination with vaccine-hesitant parents. Know how to accurately diagnose influenza in children in the midst of the COVID-19 pandemic. And lastly, learn which influenza treatments are approved for children and the role antivirals play in influenza prophylaxis in this population. Hosts: Robert H. Hopkins Jr., MD, FACP, FAAP; Charles Vega, MD, FAAFP Executive Producer: Margaret Oliverio, MD
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/influenza-populations-at-high-risk-1 Overview: This brief podcast will answer your most salient questions about managing influenza in high-risk patients, starting with how to identify those patients and determine their risk for developing complications. Next, you will listen to the experts discuss the latest CDC and IDSA recommendations for preventing influenza—including the use of post-exposure prophylaxis—in this vulnerable patient population. Finally, you will hear the recommendations for testing for influenza—within the context of the COVID-19 pandemic—and treating patients with influenza at high risk for complications Hosts: Mary W. Montgomery, MD; Charles Vega, MD, FAAFP Executive Producer: Margaret Oliverio, MD
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/influenza-populations-at-high-risk-3 Overview: Join us to discover why it is important to prevent influenza and treat patients with influenza who have cardiometabolic disease. After this brief podcast, you will be able to identify the types of cardiovascular and metabolic diseases that put patients at high risk of influenza complications and determine which patients should get the high-dose influenza vaccine, according to recent data. You will also be able to answer the question of whether anti-influenza drugs affect the risk of incident cardiovascular events. Find out all this and more to protect your patients with cardiometabolic disease this influenza season. Hosts: Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Charles Vega, MD, FAAFP Executive Producer: Margaret Oliverio, MD
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/influenza-populations-at-high-risk-2 Overview: This expert-led podcast arms you with what you need to know to effectively manage influenza in older adults, a population at increased risk for complications. Get the latest guidance on everything from choosing the appropriate vaccine for this age group to preventing the spread of influenza in long-term care facilities. Hear the most up-to-date recommendations for how to diagnose and treat older adults with influenza and find out if there are any risks associated with antivirals for this patient population. If you provide care to older adults this influenza season, you can't miss this session. Hosts: Mary W. Montgomery, MD; Charles Vega, MD, FAAFP Executive Producer: Margaret Oliverio, MD
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-245 Overview: When your patient has an elevated screening PSA level, your first inclination may be to refer for a biopsy, but have you considered obtaining a pre-biopsy MRI? In this podcast, we will review the appropriate management for an elevated screening PSA. You'll want to hear about the new benefit of obtaining a pre-biopsy MRI to guide diagnostic procedures. Episode resource links: NEJM July 9, 2021; DOI: 10.1056/NEJMoa2100852 Urology 2016 Apr;90:32-7. doi: 10.1016/j.urology.2015.11.046 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/early-action-in-hcc-episode-one Overview: This podcast is the first in a three-part series addressing the urgency for early identification and improved care for hepatocellular carcinoma (HCC). In this episode, two experts discuss the prevalence and mortality rates associated with liver cancer and highlight disparities impacting this patient population. Guideline recommendations to improve screening/referral will also be covered. Guest: Ghassan Abou-Alfa, MD, MBA
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-244 Overview: Suicide and attempted suicide are significant health issues affecting the United States and the world. Are you aware of the tools available to you that can support suicide prevention strategies and save lives? Don't miss this session to learn about how the use of an electronic health record in a large health system may help predict suicide attempts. Episode resource links: Walsh CG, Johnson KB, Ripperger M, Sperry S, Harris J, Clark N, Fielstein E, Novak L, Robinson K, Stead WW. Prospective Validation of an Electronic Health Record-Based, Real-Time Suicide Risk Model. JAMA Netw Open. 2021 Mar 1;4(3):e211428. doi: 10.1001/jamanetworkopen.2021.1428. PMID: 33710291; PMCID: PMC7955273 doi: 10.1001/jamanetworkopen.2021.1428 Liang, Angela, and Paul Nestadt S . "Suicide Risk in the COVID-19 Pandemic." Johns Hopkins Psychiatry Guide, 2021. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787393/all/Suicide_Risk_in_the_COVID_19_Pandemic. Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-243 Overview: Evidence strongly supports a correlation between hearing impairment in older adults and decline in physical functioning. A recent population cohort study of older adults revealed that hearing impairment was associated with poorer physical function, reduced walking endurance, and accelerated decline. Join us while we discuss this evidence and how to apply it to your practice. You'll walk away with strategies to promote hearing assessment and to help optimize physical functioning in your older adult patients. Episode resource links: Brenowitz WD, Wallhagen MI. Does Hearing Impairment Affect Physical Function?: Current Evidence, Potential Mechanisms, and Future Research Directions for Healthy Aging. JAMA Netw Open. 2021 Jun 1;4(6):e2114782. doi: 10.1001/jamanetworkopen.2021.14782. PMID: 34170308. Martinez-Amezcua P, Powell D, Kuo PL, Reed NS, Sullivan KJ, Palta P, Szklo M, Sharrett R, Schrack JA, Lin FR, Deal JA. Association of Age-Related Hearing Impairment With Physical Functioning Among Community-Dwelling Older Adults in the US. JAMA Netw Open. 2021 Jun 1;4(6):e2113742. doi: 10.1001/jamanetworkopen.2021.13742. PMID: 34170305; PMCID: PMC8233700. Martinez-Amezcua P, Kuo PL, Reed NS, Simonsick EM, Agrawal Y, Lin FR, Deal JA, Ferrucci L, Schrack JA. Association of hearing impairment with higher level physical functioning and walking endurance: Results from the Baltimore Longitudinal Study of Aging (BLSA). J Gerontol A Biol Sci Med Sci. 2021 May 18:glab144. doi: 10.1093/gerona/glab144. Epub ahead of print. PMID: 34003883. Croll, P.H., Vinke, E.J., Armstrong, N.M. et al. Hearing loss and cognitive decline in the general population: a prospective cohort study. J Neurol 268, 860–871 (2021). https://doi.org/10.1007/s00415-020-10208-8 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-242 Overview: Gluten exposure is known to cause a number of problems in both those with celiac disease and those with non-celiac gluten sensitivity. One aspect that has not received much attention from the research community is the neurocognitive impairment that can occur following gluten exposure in these individuals. Join us for this podcast to dive into a recent article that describes these effects. Episode resource links: Edwards George JB, Aideyan B, Yates K, et al. Gluten-induced Neurocognitive Impairment: Results of a Nationwide Study [published online ahead of print, 2021 May 28]. J Clin Gastroenterol. 2021 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-242 Overview: Gluten exposure is known to cause a number of problems in both those with celiac disease and those with non-celiac gluten sensitivity. One aspect that has not received much attention from the research community is the neurocognitive impairment that can occur following gluten exposure in these individuals. Join us for this podcast to dive into a recent article that describes these effects. Episode resource links: Edwards George JB, Aideyan B, Yates K, et al. Gluten-induced Neurocognitive Impairment: Results of a Nationwide Study [published online ahead of print, 2021 May 28]. J Clin Gastroenterol. 2021 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-241 Overview: Seven percent of the US population has an active levothyroxine prescription, which is significantly greater than the number of people diagnosed with overt hypothyroidism. Many of these prescriptions appear to be for the treatment of subclinical hypothyroidism and other conditions in euthyroid individuals. Join us to uncover the latest findings on the use of levothyroxine and what the evidence tells us about appropriate use and misuse of this drug. Episode resource links: Brito, J., Ross, J., El Kawkgi, O., Maraka, S., Deng, Y., Shah, N., Lipska, K. & (9000). Levothyroxine Use in the United States, 2008-2018. JAMA Internal Medicine, Publish Ahead of Print, doi: 10.1001/jamainternmed.2021.2686. Johansen, M., Marcinek, J., Yun, J. & (2020). Thyroid Hormone Use in the United States, 1997–2016. Journal of the American Board of Family Medicine, 33 (2), 284-288. doi: 10.3122/jabfm.2020.02.190159. Jeffrey R. Garber, Rhoda H. Cobin,Hossein Gharib,James V. Hennessey, Irwin Klein, Jeffrey I. Mechanick, Rachel Pessah-Pollack, Peter A. Singer,Kenneth A. Woeber. Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association; November–December 2012. https://www.endocrinepractice.org/article/S1530-891X(20)43030-7/fulltext; https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943030-7 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-241 Overview: Seven percent of the US population has an active levothyroxine prescription, which is significantly greater than the number of people diagnosed with overt hypothyroidism. Many of these prescriptions appear to be for the treatment of subclinical hypothyroidism and other conditions in euthyroid individuals. Join us to uncover the latest findings on the use of levothyroxine and what the evidence tells us about appropriate use and misuse of this drug. Episode resource links: Brito, J., Ross, J., El Kawkgi, O., Maraka, S., Deng, Y., Shah, N., Lipska, K. & (9000). Levothyroxine Use in the United States, 2008-2018. JAMA Internal Medicine, Publish Ahead of Print, doi: 10.1001/jamainternmed.2021.2686. Johansen, M., Marcinek, J., Yun, J. & (2020). Thyroid Hormone Use in the United States, 1997–2016. Journal of the American Board of Family Medicine, 33 (2), 284-288. doi: 10.3122/jabfm.2020.02.190159. Jeffrey R. Garber, Rhoda H. Cobin,Hossein Gharib,James V. Hennessey, Irwin Klein, Jeffrey I. Mechanick, Rachel Pessah-Pollack, Peter A. Singer,Kenneth A. Woeber. Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association; November–December 2012. https://www.endocrinepractice.org/article/S1530-891X(20)43030-7/fulltext; https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943030-7 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-240 Overview: Have you considered continuous glucose monitoring (CGM) for your patients with suboptimally controlled type 2 diabetes mellitus (T2DM) on at least 3 injections of insulin per day? This session will give you the information you need to confidently initiate CGM in appropriate patients. You'll walk away with a clear understanding of the different CGM options and the benefits and challenges of CGM. Episode resource links: Ida S, Kaneko R, Murata K. Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2019 Jan 15;2019:4684815. doi: 10.1155/2019/4684815. PMID: 30775385; PMCID: PMC6350576. Maiorino et al. Diabetes Care. 2020;43:1146–1156 Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-240 Overview: Have you considered continuous glucose monitoring (CGM) for your patients with suboptimally controlled type 2 diabetes mellitus (T2DM) on at least 3 injections of insulin per day? This session will give you the information you need to confidently initiate CGM in appropriate patients. You'll walk away with a clear understanding of the different CGM options and the benefits and challenges of CGM. Episode resource links: Ida S, Kaneko R, Murata K. Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2019 Jan 15;2019:4684815. doi: 10.1155/2019/4684815. PMID: 30775385; PMCID: PMC6350576. Maiorino et al. Diabetes Care. 2020;43:1146–1156 Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-239 Overview: Join us to discuss the CDC's new guidelines for the management of sexually transmitted infections due to Neisseria gonorrhoeae. You'll walk away with recommendations for how to address urogenital, rectal, and pharyngeal infections. You'll also discover alternative regimens for patients allergic to first-line therapy and understand how to manage coinfection with chlamydia. Episode resource links: St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1911–191 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-239 Overview: Join us to discuss the CDC's new guidelines for the management of sexually transmitted infections due to Neisseria gonorrhoeae. You'll walk away with recommendations for how to address urogenital, rectal, and pharyngeal infections. You'll also discover alternative regimens for patients allergic to first-line therapy and understand how to manage coinfection with chlamydia. Episode resource links: St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1911–191 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238 Overview: Join us to discuss important changes in the 2021 USPSTF recommendation on lung cancer screening. Given lung cancer's high prevalence and poor prognosis in later stages, it is important for primary care clinicians to know which patients to screen and what method to use. You'll also learn the appropriate time to stop screening. Episode resource links: Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238 Overview: Join us to discuss important changes in the 2021 USPSTF recommendation on lung cancer screening. Given lung cancer's high prevalence and poor prognosis in later stages, it is important for primary care clinicians to know which patients to screen and what method to use. You'll also learn the appropriate time to stop screening. Episode resource links: Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-237 Overview: Solid evidence shows that adverse pregnancy outcomes (APOs) correlate with an increased risk of cardiovascular disease (CVD) in women. Evidence is also becoming clearer that lactation and breastfeeding may have CV protective benefits as well. Social determinants of health play a significant role in these diseases; facts support that Black, Hispanic and Asian American women suffer from worse pregnancy outcomes than White American women. Join us while we discuss the recent American Heart Association (AHA) guideline update regarding the association of increased risk of CVD and metabolic disease with APOs and what can be done to reduce these risks. Episode resource links: Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women. Nisha I. Parikh, MD, MPH, Chair, Juan M. Gonzalez, MD, Cheryl A.M. Anderson, PhD, Suzanne E. Judd, PhD, Kathryn M. Rexrode, MD, Mark A. Hlatky, MD, Erica P. Gunderson, PhD, Jennifer J. Stuart, ScD, Dhananjay Vaidya, PhD, Vice Chair, On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. https://www.ahajournals.org/doi/abs/10.1161/CIR.000000000000096 Schwartz, EB. (reviewing Parikh NI et al. Circulation 2021 Mar 29). Preventing Heart Disease in Women: New Guidance from the American Heart Association. NEJM: Journal Watch, April 12, 2021. https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart?ijkey=3l3eCvQLl Clinical Statements and Guidelines. AHA/ACOG Presidential Advisory. Volume 137, Issue 24, 12 June 2018, Pages e843-e852. https://doi.org/10.1161/CIR.0000000000000582 https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-237 Overview: Solid evidence shows that adverse pregnancy outcomes (APOs) correlate with an increased risk of cardiovascular disease (CVD) in women. Evidence is also becoming clearer that lactation and breastfeeding may have CV protective benefits as well. Social determinants of health play a significant role in these diseases; facts support that Black, Hispanic and Asian American women suffer from worse pregnancy outcomes than White American women. Join us while we discuss the recent American Heart Association (AHA) guideline update regarding the association of increased risk of CVD and metabolic disease with APOs and what can be done to reduce these risks. Episode resource links: Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women. Nisha I. Parikh, MD, MPH, Chair, Juan M. Gonzalez, MD, Cheryl A.M. Anderson, PhD, Suzanne E. Judd, PhD, Kathryn M. Rexrode, MD, Mark A. Hlatky, MD, Erica P. Gunderson, PhD, Jennifer J. Stuart, ScD, Dhananjay Vaidya, PhD, Vice Chair, On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. https://www.ahajournals.org/doi/abs/10.1161/CIR.000000000000096 Schwartz, EB. (reviewing Parikh NI et al. Circulation 2021 Mar 29). Preventing Heart Disease in Women: New Guidance from the American Heart Association. NEJM: Journal Watch, April 12, 2021. https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart?ijkey=3l3eCvQLl Clinical Statements and Guidelines. AHA/ACOG Presidential Advisory. Volume 137, Issue 24, 12 June 2018, Pages e843-e852. https://doi.org/10.1161/CIR.0000000000000582 https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-236 Overview: Continuous glucose monitoring (CGM) for patients with diabetes has been available for several years now, but its utility in managing diabetes care is unclear. Join us to discuss the results of a systematic review examining the benefits of CGM for patients with both type 1 and type 2 diabetes mellitus. Episode resource links: Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156 Implementing Continuous Glucose Monitoring in Clinical Practice. www.aafp.org/fpm March/April 2021 Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193. Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-236 Overview: Continuous glucose monitoring (CGM) for patients with diabetes has been available for several years now, but its utility in managing diabetes care is unclear. Join us to discuss the results of a systematic review examining the benefits of CGM for patients with both type 1 and type 2 diabetes mellitus. Episode resource links: Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156. Implementing Continuous Glucose Monitoring in Clinical Practice. www.aafp.org/fpm March/April 2021 Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193. Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/severe-asthma-how-eosinophils-impact-evaluation-treatment Overview: Did you know that approximately two-thirds of adults with severe asthma are eosinophilic? The presence of eosinophilia can have implications for asthma management as well. Join Dr. Nicola Hanania, pulmonologist and asthma expert, as he reviews the case of a patient with severe asthma and discusses how primary care clinicians can identify eosinophilia, using common biomarkers, and improve outcomes in patients with eosinophilic asthma. Guest: Nicola Hanania, MD, MS, FACP, FCCP, FRCPC
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235 Overview: Perennial allergic rhinitis affects both children and adults, and management includes both allergy avoidance as well as medication management. Intranasal steroids are the mainstay of treatment and have traditionally required consistent use, but new data are emerging. Find out the results of a new study evaluating PRN use as an alternative approach. Episode resource links: Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1365-1373 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235 Overview: Perennial allergic rhinitis affects both children and adults, and management includes both allergy avoidance as well as medication management. Intranasal steroids are the mainstay of treatment and have traditionally required consistent use, but new data are emerging. Find out the results of a new study evaluating PRN use as an alternative approach. Episode resource links: Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1365-1373 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234 Overview: Many providers overtreat outpatient infections for fear of not treating until resolution or causing a complication, but this can lead to antibiotic resistance and adverse events. Join us to discuss the new ACP guidelines on antibiotic use in the outpatient setting and the pediatric treatment recommendations. Walk away with a clear understanding of the guidelines for optimal duration of antibiotic treatment for individuals with an outpatient infection. Episode resource links: ACP: Ann Intern Med. doi:10.7326/M20-7355; https://www.acpjournals.org/doi/pdf/10.7326/M20-7355 Low risk for PCN allergy: Am J Respir Crit Care Med 2020 Feb 21; [e-pub]. (https://doi.org/10.1164/rccm.202001-0089LE); Mayo Clinic Proceedings 2018, 93 (1): 101-107 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234 Overview: Many providers overtreat outpatient infections for fear of not treating until resolution or causing a complication, but this can lead to antibiotic resistance and adverse events. Join us to discuss the new ACP guidelines on antibiotic use in the outpatient setting and the pediatric treatment recommendations. Walk away with a clear understanding of the guidelines for optimal duration of antibiotic treatment for individuals with an outpatient infection. Episode resource links: ACP: Ann Intern Med. doi:10.7326/M20-7355; https://www.acpjournals.org/doi/pdf/10.7326/M20-7355 Low risk for PCN allergy: Am J Respir Crit Care Med 2020 Feb 21; [e-pub]. (https://doi.org/10.1164/rccm.202001-0089LE); Mayo Clinic Proceedings 2018, 93 (1): 101-107 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-233 Overview: T2DM is an epidemic, and its impact on quantity of life is well documented. In most cases, treatment involves significant lifestyle changes in combination with medication. Distress about the T2DM diagnosis and necessary behavioral changes occurs in about one-third of people, and this distress is associated with poor glycemic management. Join us as we discuss a recent meta-analysis on mindfulness and learn how cognitive therapies may be effective in reducing distress and HbA1c. Episode resource links: Ngan, H.Y., Chong, Y.Y. and Chien, W.T. (2021), Effects of mindfulness‐ and acceptance‐based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta‐analysis. Diabet Med, 38: e14525. https://doi.org/10.1111/dme.14525; https://onlinelibrary-wiley-com.umassmed.idm.oclc.org/doi/epdf/10.1111/dme.14525 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-233 Overview: T2DM is an epidemic, and its impact on quantity of life is well documented. In most cases, treatment involves significant lifestyle changes in combination with medication. Distress about the T2DM diagnosis and necessary behavioral changes occurs in about one-third of people, and this distress is associated with poor glycemic management. Join us as we discuss a recent meta-analysis on mindfulness and learn how cognitive therapies may be effective in reducing distress and HbA1c. Episode resource links: Ngan, H.Y., Chong, Y.Y. and Chien, W.T. (2021), Effects of mindfulness‐ and acceptance‐based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta‐analysis. Diabet Med, 38: e14525. https://doi.org/10.1111/dme.14525; https://onlinelibrary-wiley-com.umassmed.idm.oclc.org/doi/epdf/10.1111/dme.14525 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-232 Overview: For patients with community-acquired pneumonia (CAP), wide variation in the duration of treatment exists. Longer duration of treatment may increase the risk of adverse effects and lead to antibiotic resistance. However, shorter duration of treatment may result in treatment failure. See what new evidence shows may be the best antibiotics treatment duration in most patients with CAP. Episode resource links: Dinh A et al. Pneumonia Short Treatment (PTC) Study Group. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021 Mar 27;397(10280):1195-1203 Metlay JP et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-232 Overview: For patients with community-acquired pneumonia (CAP), wide variation in the duration of treatment exists. Longer duration of treatment may increase the risk of adverse effects and lead to antibiotic resistance. However, shorter duration of treatment may result in treatment failure. See what new evidence shows may be the best antibiotics treatment duration in most patients with CAP. Episode resource links: Dinh A et al. Pneumonia Short Treatment (PTC) Study Group. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021 Mar 27;397(10280):1195-1203 Metlay JP et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231 Overview: Who couldn't use a refresher on how to diagnose and treat neck pain in the primary care setting? Review the techniques for assessing neck pain, determining its cause, and providing relief. Immediately apply what you learn to start helping patients with neck pain feel better. Episode resource links: Am Fam Physician 2016 May 1;93(9):746-54. Sub occipital Release: J Electromyogr Kinesiol 2016 Oct;30:31-7. doi: 10.1016/j.jelekin.2016.05.007 Self Myofascial Release: Spine 2020 Nov 1;45(21):E1367-E1375 Guest: Robert A. Baldor MD, FAAFP/Frank Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231 Overview: Who couldn't use a refresher on how to diagnose and treat neck pain in the primary care setting? Review the techniques for assessing neck pain, determining its cause, and providing relief. Immediately apply what you learn to start helping patients with neck pain feel better. Episode resource links: Am Fam Physician 2016 May 1;93(9):746-54. Sub occipital Release: J Electromyogr Kinesiol 2016 Oct;30:31-7. doi: 10.1016/j.jelekin.2016.05.007 Self Myofascial Release: Spine 2020 Nov 1;45(21):E1367-E1375 Guest: Robert A. Baldor MD, FAAFP/Frank Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/stop-hiv-together-2 Overview: The Ending the HIV Epidemic (EHE) initiative aims to reduce new HIV infections in the U.S. by 90% by 2030. This aim will be achieved by equitably and collaboratively delivering care and focusing resources on communities most affected by HIV, including those in Southern and rural areas. Join Dr. Charles Vega, Health Sciences Clinical Professor at UC Irvine Department of Family Medicine, and Dr. Leandro Mena, Chair and Professor of the Department of Population Health Science at University of Mississippi, and Director of the Center for HIV/AIDS Research, as they discuss how to provide culturally competent and collaborative care using the four EHE strategies: diagnose, treat, prevent, and respond. Guest: Leandro Mena, MD, MPH
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/stop-hiv-together-1 Overview: HIV remains a persistent health problem for the United States and countries around the world. June marks 40 years since the first report of AIDS in CDC's MMWR. Great progress has happened in the last 40 years in preventing and treating HIV. Yet there is still much to do. Join Dr. Charles Vega, Health Sciences Clinical Professor at UC Irvine Department of Family Medicine, and Dr. Oni Blackstock, primary care and HIV physician, researcher, and founder and executive director of Health Justice, racial and health equity consulting practice as they discuss how health and social inequities continue to affect the HIV epidemic. They will talk about the role primary care providers can play in ending the HIV epidemic. Guest: Oni Blackstock, MD, MHS
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230 Overview: Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you'll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you'll walk away with practical knowledge to help these patients minimize their risk of adverse events. Episode resource links: Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med.2019; 179(11 ): 1469-14 78. doi: 10.1001 /jamainternmed.2019.2431 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230 Overview: Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you'll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you'll walk away with practical knowledge to help these patients minimize their risk of adverse events. Episode resource links: Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med.2019; 179(11 ): 1469-14 78. doi: 10.1001 /jamainternmed.2019.2431 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-229 Overview: Ample evidence shows that adverse childhood experiences (ACEs) and trauma in adulthood may lead to poor health outcomes, such as cardiovascular disease and other chronic diseases. These traumas may also affect a person's inclination to seek care and participate in plans of care. As a provider, it is important to consider this history and ensure the psychological and physical safety of these affected individuals. Join us to learn proven strategies to help you practice trauma-informed care, including how to recognize trauma and offer effective interventions to help patients dealing with these issues. Episode resource links: ACOG Committee Decision: Caring for Patients who have Experienced Trauma. Obstetrics and Gynecology. VOL. 37, NO. 4. April 2021. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/04/caring-for-patients-who-have-experienced-trauma Dicola, D. & Spaar, E. Intimate Partner Violence. American Family Physician. October 15, 2016, VOL. 94, NO. 8. www.aafp.org/afp https://www.cdc.gov/violenceprevention/aces/index.html https://store.samhsa.gov/sites/default/files/d7/priv/sma14-4816.pdf Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.50 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/stop-hiv-together-2 Overview: The Ending the HIV Epidemic (EHE) initiative aims to reduce new HIV infections in the U.S. by 90% by 2030. This aim will be achieved by equitably and collaboratively delivering care and focusing resources on communities most affected by HIV, including those in Southern and rural areas. Join Dr. Charles Vega, Health Sciences Clinical Professor at UC Irvine Department of Family Medicine, and Dr. Leandro Mena, Chair and Professor of the Department of Population Health Science at University of Mississippi, and Director of the Center for HIV/AIDS Research, as they discuss how to provide culturally competent and collaborative care using the four EHE strategies: diagnose, treat, prevent, and respond. Guest: Leandro Mena, MD, MPH
Credits: 0.50 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/stop-hiv-together-1 Overview: HIV remains a persistent health problem for the United States and countries around the world. June marks 40 years since the first report of AIDS in CDC's MMWR. Great progress has happened in the last 40 years in preventing and treating HIV. Yet there is still much to do. Join Dr. Charles Vega, Health Sciences Clinical Professor at UC Irvine Department of Family Medicine, and Dr. Oni Blackstock, primary care and HIV physician, researcher, and founder and executive director of Health Justice, racial and health equity consulting practice as they discuss how health and social inequities continue to affect the HIV epidemic. They will talk about the role primary care providers can play in ending the HIV epidemic. Guest: Oni Blackstock, MD, MHS
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-229 Overview: Ample evidence shows that adverse childhood experiences (ACEs) and trauma in adulthood may lead to poor health outcomes, such as cardiovascular disease and other chronic diseases. These traumas may also affect a person's inclination to seek care and participate in plans of care. As a provider, it is important to consider this history and ensure the psychological and physical safety of these affected individuals. Join us to learn proven strategies to help you practice trauma-informed care, including how to recognize trauma and offer effective interventions to help patients dealing with these issues. Episode resource links: ACOG Committee Decision: Caring for Patients who have Experienced Trauma. Obstetrics and Gynecology. VOL. 37, NO. 4. April 2021. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2021/04/caring-for-patients-who-have-experienced-trauma Dicola, D. & Spaar, E. Intimate Partner Violence. American Family Physician. October 15, 2016, VOL. 94, NO. 8. www.aafp.org/afp https://www.cdc.gov/violenceprevention/aces/index.html https://store.samhsa.gov/sites/default/files/d7/priv/sma14-4816.pdf Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-228 Overview: Join us for this episode as we discuss the results of a systematic review examining the benefits and risks from delaying the use of antibiotics to treat patients in the community for a respiratory infection. Episode resource links: Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ 2021;372:n808 http://dx.doi.org/10.1136/bmj.n808 Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-228 Overview: Join us for this episode as we discuss the results of a systematic review examining the benefits and risks from delaying the use of antibiotics to treat patients in the community for a respiratory infection. Episode resource links: Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ 2021;372:n808 http://dx.doi.org/10.1136/bmj.n808 Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-227 Overview: Join us as we discuss a recent review article on the evidence behind monofilament testing for peripheral neuropathy in people with diabetes. Episode resource links: J Diabetes Res. 2017; 2017: 8787261. Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis Diabetes Care 2017 Jan;40(1):136-154 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-227 Overview: Join us as we discuss a recent review article on the evidence behind monofilament testing for peripheral neuropathy in people with diabetes. Episode resource links: J Diabetes Res. 2017; 2017: 8787261. Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis Diabetes Care 2017 Jan;40(1):136-154 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-226 Overview: Patients with a history of transient ischemic attack (TIA) are at increased risk of stroke in the future. The ABCD2 score is the most used risk assessment tool for people with acute TIA, but it is not recommended for this purpose by the National Institute for Heath and Care Excellence (NICE). Join us for today's episode as we describe a new validated risk assessment tool developed in Canada you can use to classify patients as low, medium, or high-risk for stroke over the 7 days following a TIA. Episode References and Resource Links: Perry JJ et al. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study. BMJ. 2021 Feb 4;372:n49 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-226 Overview: Patients with a history of transient ischemic attack (TIA) are at increased risk of stroke in the future. The ABCD2 score is the most used risk assessment tool for people with acute TIA, but it is not recommended for this purpose by the National Institute for Heath and Care Excellence (NICE). Join us for today’s episode as we describe a new validated risk assessment tool developed in Canada you can use to classify patients as low, medium, or high-risk for stroke over the 7 days following a TIA. Episode References and Resource Links: Perry JJ et al. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study. BMJ. 2021 Feb 4;372:n49 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225 Overview: Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients. Episode resource links: JAMA.2020;3(12):e2025190.doi:10.1001/jamanetworkopen.2020.25190 JAMA. 2018;319(24):2521-2531. doi:10.1001/jama.2018.7498 https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225 Overview: Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients. Episode resource links: JAMA.2020;3(12):e2025190.doi:10.1001/jamanetworkopen.2020.25190 JAMA. 2018;319(24):2521-2531. doi:10.1001/jama.2018.7498 https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-224 Overview: More than 250 million individuals worldwide have osteoarthritis (OA) of the knee and the burden on individuals and healthcare systems is enormous. There is no cure for OA, with treatments such as NSAIDs and acetaminophen aimed towards symptom reduction and improved functioning. Most evidence-based guidelines include the use of supportive shoes, however little evidence exists on effectiveness of these types of shoes. It is also unclear what the characteristics of a supportive shoe are and what type of shoe is best for OA. Join us as we discuss a recent randomized controlled trial that compared 2 types of shoes, and their benefits in symptom reduction and functional improvement of knee OA Episode resource links: AAOS EBG: Lateral Wedge Insole. https://www.orthoguidelines.org/guideline-detail?id=1209&tab=all_guidelines AAOS EBG Treatment of Osteoarthritis of the Knee; https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/osteoarthritis-of-the-knee-2nd-editiion-clinical-practice-guideline.pdf Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-224 Overview: More than 250 million individuals worldwide have osteoarthritis (OA) of the knee and the burden on individuals and healthcare systems is enormous. There is no cure for OA, with treatments such as NSAIDs and acetaminophen aimed towards symptom reduction and improved functioning. Most evidence-based guidelines include the use of supportive shoes, however little evidence exists on effectiveness of these types of shoes. It is also unclear what the characteristics of a supportive shoe are and what type of shoe is best for OA. Join us as we discuss a recent randomized controlled trial that compared 2 types of shoes, and their benefits in symptom reduction and functional improvement of knee OA Episode resource links: AAOS EBG: Lateral Wedge Insole. https://www.orthoguidelines.org/guideline-detail?id=1209&tab=all_guidelines AAOS EBG Treatment of Osteoarthritis of the Knee; https://www.aaos.org/globalassets/quality-and-practice-resources/osteoarthritis-of-the-knee/osteoarthritis-of-the-knee-2nd-editiion-clinical-practice-guideline.pdf Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/pmi-contraception-2 Overview: Would you like to improve your skills in counseling patients about contraception and learn strategies to support them in choosing the best option for them? Listen to episode 2 of this 2-part series podcast on contraception, where family planning specialist Kate White, MD and primary care physician Pamela Kushner, MD review important clinical considerations in prescribing contraception and discuss effective strategies for counseling patients about their options. Episode resource links: https://www.bedsider.org/ https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html https://www.cdc.gov/reproductivehealth/contraception/mmwr/spr/summary.html Guest: Pamela Kushner, MD, FAAFP
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/pmi-contraception-1 Overview: Are you curious about recent updates in contraceptive options for your patients? Do you want to improve or just refresh your knowledge of hormonal contraceptive options outside of the pill? Listen to family planning specialist Dr. Kate White as she is interviewed by primary care physician Dr. Pamela Kushner about updates in hormonal contraceptive options and they review the benefits of other hormonal contraceptive options like the ring, patch, injection, implant, and intrauterine devices. In episode 1 of this 2-part series podcast, they will review newly approved hormonal contraceptive options and discuss why and how to consider options other than the pill for patients. Episode resource links: https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html https://www.cdc.gov/reproductivehealth/contraception/mmwr/spr/summary.html Guest: Pamela Kushner, MD, FAAFP
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-223 Overview: Clinical psychologist Dr. Christine Runyan joins host, Dr. Frank Domino, in today’s episode to discuss the various self-care methods to help healthcare workers overcome stressors related to the COVID-19 pandemic, and to describe the potential future impact of the COVID-19 crisis on this population. Episode resource links: https://tend.health/ https://www.pri-med.com/online-education/webcast/west-2019-well-being https://www.pri-med.com/online-education/podcast/pri-med-podcasts-well-being Guest: Christine Runyan, PhD, ABPP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-223 Overview: Clinical psychologist Dr. Christine Runyan joins host, Dr. Frank Domino, in today’s episode to discuss the various self-care methods to help healthcare workers overcome stressors related to the COVID-19 pandemic, and to describe the potential future impact of the COVID-19 crisis on this population. Episode resource links: https://tend.health/ https://www.pri-med.com/online-education/webcast/west-2019-well-being https://www.pri-med.com/online-education/podcast/pri-med-podcasts-well-being Guest: Christine Runyan, PhD, ABPP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-222 Overview: Join us for this episode as we discuss a recent Cochrane review of the safety and effectiveness of topical treatments for toenail onychomycosis, and review when and how to prescribe these agents for patients. Episode resource links: Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev. 2020; (1): CD012093 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-222 Overview: Join us for this episode as we discuss a recent Cochrane review of the safety and effectiveness of topical treatments for toenail onychomycosis, and review when and how to prescribe these agents for patients. Episode resource links: Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev. 2020; (1): CD012093 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-221 Overview: Join us as we discuss another finding of the Nurses Health Study II—this podcast focuses on the findings of a prospective look at GERD, and the effect of diet and lifestyle on the prevention of GERD. Episode resource links: Mehta RS, Nguyen LH, Ma W, Staller K, Song M, Chan AT. Association of Diet and Lifestyle With the Risk of Gastroesophageal Reflux Disease Symptoms in US Women. JAMA Intern Med. Published online January 04, 2021. doi:10.1001/jamainternmed.2020.7238 For Patients: Eating, Diet, & Nutrition for GER & GERD https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/eating-diet-nutrition Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-221 Overview: Join us as we discuss another finding of the Nurses Health Study II -this podcast focuses on the findings of a prospective look at GERD, and the effect of diet and lifestyle on the prevention of GERD. Episode resource links: Mehta RS, Nguyen LH, Ma W, Staller K, Song M, Chan AT. Association of Diet and Lifestyle With the Risk of Gastroesophageal Reflux Disease Symptoms in US Women. JAMA Intern Med. Published online January 04, 2021. doi:10.1001/jamainternmed.2020.7238 For Patients: Eating, Diet, & Nutrition for GER & GERD https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/eating-diet-nutrition Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato
Credits: 0.5 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/coffee-with-chopra-ep-4 Overview: Join Dr. Sanjiv Chopra in this installment of Coffee with Chopra, as he interviews his guest, Dr. Melanie Hoenig, about advances in nephrology. In this session, the duo will discuss topics including: race and kidney function, HIV and HCV on kidney function, and the relationship between APOL1 and kidney failure. Episode resource links: https://jamanetwork.com/journals/jama/article-abstract/2735726 https://www.kidney-international.org/article/S0085-2538(17)30823-2/fulltext https://www.jci.org/articles/view/46263/figure/1 https://www.nytimes.com/2020/06/17/health/many-medical-decision-tools-disadvantage-black-patients.html Guest: Melanie Hoenig, MD
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-220 Overview: Join us for this episode as we review a recent meta-analysis that addresses best treatment modalities for adhesive capsulitis. Episode resource links: JAMA Netw Open. 2020 Dec 1;3(12):e2029581. Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-219 Overview: The COVID pandemic and the precautionary changes in behavior put into practice are creating an immeasurable cost in ways that are still being identified – social isolation, stresses on mental health, as well as neglect of chronic disease management – to name a few. In a recent study out of China, it was found that 6, 7 and 8-year-olds had a significant increase in myopia associated with the lockdown and school closures. This level of myopia places these children at much greater risk of poor vision in adulthood. Join us as we discuss these findings and how they may impact prevention strategies and assessment parameters in children during and after the pandemic. Episode References: Klaver CCW, Polling JR, Enthoven CA. 2020 as the Year of Quarantine Myopia. JAMA Ophthalmol. Published online January 14, 2021. doi:10.1001/jamaophthalmol.2020.6231 Wang J, Li Y, Musch DC, et al. Progression of Myopia in School-Aged Children After COVID-19 Home Confinement. JAMA Ophthalmol. Published online January 14, 2021. doi:10.1001/jamaophthalmol.2020.6239 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-218 Overview: Join us for this session where we will discuss the data behind the recent USPSTF recommendations on the use of ASA as a colorectal cancer (CRC) preventive agent, and when to incorporate this recommendation into practice. Episode resource links: www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer doi:10.1001/jamaoncol.2020.7338 N Engl J Med 2018; 379:1519-1528 DOI: 10.1056/NEJMoa1803955 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato